Viewing Study NCT00082966


Ignite Creation Date: 2025-12-24 @ 4:22 PM
Ignite Modification Date: 2025-12-28 @ 9:18 PM
Study NCT ID: NCT00082966
Status: COMPLETED
Last Update Posted: 2015-12-04
First Post: 2004-05-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bortezomib in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
Sponsor: National Cancer Institute (NCI)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module